Skip to main navigation Skip to search Skip to main content

A 12-gene pharmacogenetic panel to prevent adverse drug reactions: an open-label, multicentre, controlled, cluster-randomised crossover implementation study

  • Ubiquitous Pharmacogenomics Consortium
  • Leiden University Medical Center
  • Medical University of Vienna
  • University of Ljubljana
  • CNRS
  • Experimental and Clinical Pharmacology Unit
  • Medicines Information Centre
  • Service de pharmacologie médicale et clinique
  • Karolinska Institutet
  • Uppsala University
  • University Hospital of the RWTH Aachen
  • Bio.logis Digital Health
  • Saarland University
  • United Arab Emirates University
  • Université Paul Sabatier
  • The University of Liverpool
  • University of Tübingen
  • University of Patras School of Health Sciences
  • Dr Margarete Fischer-Bosch Institute of Clinical Pharmacology
  • Hospital Universitario Virgen de las Nieves

Research output: Contribution to journalArticleAcademicpeer-review

Fingerprint

Dive into the research topics of 'A 12-gene pharmacogenetic panel to prevent adverse drug reactions: an open-label, multicentre, controlled, cluster-randomised crossover implementation study'. Together they form a unique fingerprint.
Sort by

Medicine and Dentistry

Biochemistry, Genetics and Molecular Biology

Pharmacology, Toxicology and Pharmaceutical Science

Keyphrases